var data={"title":"Epidemiology, clinical manifestations, and diagnosis of psoriasis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Epidemiology, clinical manifestations, and diagnosis of psoriasis</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/contributors\" class=\"contributor contributor_credentials\">Steven R Feldman, MD, PhD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/contributors\" class=\"contributor contributor_credentials\">Robert P Dellavalle, MD, PhD, MSPH</a></dd><dd><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/contributors\" class=\"contributor contributor_credentials\">Kristina Callis Duffin, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/contributors\" class=\"contributor contributor_credentials\">Abena O Ofori, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jul 20, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Psoriasis is a common chronic inflammatory skin disease most commonly characterized by well-demarcated, erythematous plaques with silver scale (<a href=\"image.htm?imageKey=DERM%2F87343%7EDERM%2F54581%7EDERM%2F87443%7EDERM%2F87441%7EDERM%2F99437\" class=\"graphic graphic_picture graphicRef87343 graphicRef54581 graphicRef87443 graphicRef87441 graphicRef99437 \">picture 1A-E</a>) and associated with a variety of comorbidities. Other presentations, such as guttate, pustular, erythrodermic, inverse, and nail psoriasis also occur (<a href=\"image.htm?imageKey=DERM%2F99438%7EDERM%2F94790%7EDERM%2F99440%7EDERM%2F69799\" class=\"graphic graphic_picture graphicRef99438 graphicRef94790 graphicRef99440 graphicRef69799 \">picture 2A-D</a>). Most cases can be treated in the outpatient setting. Rare, life-threatening presentations are far less common than in the past due to the many highly effective systemic medications now available for treating severe psoriasis. (See <a href=\"topic.htm?path=treatment-of-psoriasis-in-adults\" class=\"medical medical_review\">&quot;Treatment of psoriasis in adults&quot;</a>.)</p><p>The epidemiology, clinical manifestations, and diagnosis of psoriatic skin disease will be reviewed here. The pathophysiology and treatment of psoriatic skin disease and issues related to psoriatic arthritis are discussed separately. In-depth discussions of the guttate and pustular variants of psoriasis and psoriasis in children are also available separately. (See <a href=\"topic.htm?path=pathophysiology-of-psoriasis\" class=\"medical medical_review\">&quot;Pathophysiology of psoriasis&quot;</a> and <a href=\"topic.htm?path=treatment-of-psoriasis-in-adults\" class=\"medical medical_review\">&quot;Treatment of psoriasis in adults&quot;</a> and <a href=\"topic.htm?path=treatment-of-psoriatic-arthritis\" class=\"medical medical_review\">&quot;Treatment of psoriatic arthritis&quot;</a> and <a href=\"topic.htm?path=pathogenesis-of-psoriatic-arthritis\" class=\"medical medical_review\">&quot;Pathogenesis of psoriatic arthritis&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-psoriatic-arthritis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of psoriatic arthritis&quot;</a> and <a href=\"topic.htm?path=guttate-psoriasis\" class=\"medical medical_review\">&quot;Guttate psoriasis&quot;</a> and <a href=\"topic.htm?path=pustular-psoriasis-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Pustular psoriasis: Pathogenesis, clinical manifestations, and diagnosis&quot;</a> and <a href=\"topic.htm?path=psoriasis-in-children-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Psoriasis in children: Epidemiology, clinical manifestations, and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Estimates of the prevalence of psoriasis have varied across studies. A systematic review of international population-based studies found wide variation in the global prevalence of psoriasis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/1\" class=\"abstract_t\">1</a>]. The prevalence of psoriasis in adults ranged from 0.91 to 8.5 percent, and the prevalence of the disease in children ranged from 0 to 2.1 percent. Geographic location influences the likelihood of having psoriasis; disease prevalence tends to increase with increasing distance from the equator. A systematic worldwide review found the prevalence of&nbsp;psoriasis ranged from 0.5 to 11.4 percent in adults and 0 to 1.4 percent in children [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/2\" class=\"abstract_t\">2</a>].</p><p>There is no clear gender predilection for psoriasis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/1,3\" class=\"abstract_t\">1,3</a>]. Although psoriasis can begin at any age, the disease is less common in children than adults. There seem to be two peaks for the age of onset: one between the ages of 30 and 39 years and another between the ages of 50 and 69 years [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/1\" class=\"abstract_t\">1</a>].</p><p>The incidence of psoriasis may be increasing. A retrospective study of a cohort of adults reported an increased incidence of psoriasis between the years 1970 to 1974 (50.8 cases per 100,000) and 1995 to 1999 (100.5 cases per 100,000) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/4\" class=\"abstract_t\">4</a>]. Another cohort study assessing the incidence of psoriasis in children also reported increasing incidence, from 29.6 cases per 100,000 to 62.7 cases per 100,000 during the same time periods [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/5\" class=\"abstract_t\">5</a>]. However, few other studies report on incidence to confirm these findings. Changes in diagnostic patterns over time also may contribute to increasing rates of diagnosis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/4\" class=\"abstract_t\">4</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">RISK FACTORS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Genetic predisposition clearly plays a role in the development of psoriasis (see <a href=\"#H28372879\" class=\"local\">'Genetic factors'</a> below). In addition, environmental and behavioral factors can affect the course of disease. </p><p class=\"headingAnchor\" id=\"H28372879\"><span class=\"h2\">Genetic factors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Psoriasis has long been known to occur in families. Examples of observations that support a contribution of genetic factors include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Approximately 40 percent of patients with psoriasis or psoriatic arthritis have a family history of these disorders in first-degree relatives [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/6\" class=\"abstract_t\">6</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Psoriasis tends to be concordant among monozygotic twins more commonly than among dizygotic twins [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/7-9\" class=\"abstract_t\">7-9</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Genome-wide association studies have identified multiple susceptibility loci for psoriasis, many of which contain genes involved in regulation of the immune system [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/10-16\" class=\"abstract_t\">10-16</a>]. </p><p/><p>The psoriasis-susceptibility (PSORS1) locus within the major histocompatibility complex (MHC) on chromosome 6p21 (location of the HLA genes) is considered a major genetic determinant of psoriasis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/17,18\" class=\"abstract_t\">17,18</a>]. Among other MHC genes that have been associated with psoriasis, HLA-Cw6 is the most important allele for susceptibility to early-onset psoriasis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/19,20\" class=\"abstract_t\">19,20</a>]. HLA-Cw6 also demonstrates a strong association with guttate psoriasis (see <a href=\"topic.htm?path=guttate-psoriasis#H1391875265\" class=\"medical medical_review\">&quot;Guttate psoriasis&quot;, section on 'Pathogenesis'</a>). HLA-B17 may be associated with a more severe phenotype [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/21\" class=\"abstract_t\">21</a>].</p><p>MHC and HLA associations explain only a portion of genetic susceptibility to psoriasis. Interleukin (IL)-23-related genes have been implicated in psoriasis, and this pathway, which involves Th17 cells, is a target for drug development. (See <a href=\"topic.htm?path=pathophysiology-of-psoriasis#H12219645\" class=\"medical medical_review\">&quot;Pathophysiology of psoriasis&quot;, section on 'Interleukin-23'</a> and <a href=\"topic.htm?path=pathophysiology-of-psoriasis#H12219659\" class=\"medical medical_review\">&quot;Pathophysiology of psoriasis&quot;, section on 'Interleukin-12'</a>.)</p><p>Genes that encode the shared subunit of the receptor for IL-12 and IL-23 have been identified as susceptibility loci for psoriasis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/15,22,23\" class=\"abstract_t\">15,22,23</a>]. Certain receptor polymorphisms appear to predispose to, or protect from, psoriasis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/22,23\" class=\"abstract_t\">22,23</a>]. In addition, the <em>IL12B</em> gene, which encodes the p40 subunit of IL-12 and IL-23, as well as the <em>IL23A</em> gene, which encodes the p19 subunit of IL-23, are strongly associated with psoriasis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/15\" class=\"abstract_t\">15</a>]. </p><p>Additional examples of genes involved in immune regulation that are linked to psoriasis include <em>TNIP1</em> and <em>TNFAIP3</em>, whose gene products act downstream of tumor necrosis factor (TNF)-alpha and regulate NF-kappaB signaling [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/15\" class=\"abstract_t\">15</a>]. Genes encoding IL-4 and IL-13, which modulate Th2 responses, and beta defensins, which are involved in innate immunity, are also implicated [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/15,24\" class=\"abstract_t\">15,24</a>]. Multiple other genes involved in the innate or adaptive immune systems may be associated with psoriasis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/16\" class=\"abstract_t\">16</a>]. As an example, late-onset psoriasis (psoriasis with onset after age 40) may be associated with polymorphisms in the <em>IL1B</em> gene [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/25\" class=\"abstract_t\">25</a>].</p><p>In addition, the LCE gene cluster on chromosome 1q21, which encodes cornified envelope proteins that are important for epidermal cell differentiation, is a susceptibility locus for psoriasis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/26\" class=\"abstract_t\">26</a>]. A genome-wide scan revealed that deletions of <em>LCE3B</em> and <em>LCE3C</em>, genes located within the LCE cluster, are associated with an increased risk of psoriasis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/27\" class=\"abstract_t\">27</a>]. </p><p>The generalized pustular psoriasis variant of psoriasis has been associated with distinct genetic mutations. The role of genetics in generalized pustular psoriasis is reviewed separately. (See <a href=\"topic.htm?path=pustular-psoriasis-pathogenesis-clinical-manifestations-and-diagnosis#H86559776\" class=\"medical medical_review\">&quot;Pustular psoriasis: Pathogenesis, clinical manifestations, and diagnosis&quot;, section on 'Genetics'</a>.)</p><p class=\"headingAnchor\" id=\"H28373348\"><span class=\"h2\">Other factors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In addition to genetics, multiple other exposures and characteristics have been proposed as risk factors or exacerbating factors for psoriasis.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Smoking </strong>&ndash; Smoking appears to be a risk factor for psoriasis. A 2014 systematic review and meta-analysis found a higher prevalence of both current and former smoking among individuals with psoriasis than among individuals without psoriasis (pooled odds ratios [OR] 1.78, 95% CI 1.52-2.06 and 1.62, 95% CI 1.33-1.99, respectively) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/28\" class=\"abstract_t\">28</a>]. In addition, a psoriasis incidence study that pooled data from the Nurses' Health Study, the Nurses' Health Study II, and the Health Professionals' Follow-up Study (comprising a total 185,836 participants, including 2410 with psoriasis) found that current or former smokers were more likely to develop psoriasis than nonsmokers [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/29\" class=\"abstract_t\">29</a>]. The intensity and duration of smoking appeared to increase risk for the development of psoriasis. Of note, palmoplantar pustulosis, which is considered by some to be a localized variant of pustular psoriasis, is strongly associated with smoking [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/30,31\" class=\"abstract_t\">30,31</a>]. (See <a href=\"topic.htm?path=palmoplantar-pustulosis-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Palmoplantar pustulosis: Epidemiology, clinical features, and diagnosis&quot;</a>.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Obesity </strong>&ndash; Psoriasis has been associated with obesity and higher body mass index (BMI) in adults and children [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/32-38\" class=\"abstract_t\">32-38</a>]. While it was traditionally thought that obesity in patients with psoriasis was a result of unhealthy behavior patterns, results from the Nurses' Health Study suggest that obesity may contribute to the development of more severe disease [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/34\" class=\"abstract_t\">34</a>]. Increased levels of proinflammatory cytokines, including TNF-alpha, in tissue or serum in obese patients may contribute to the relationship between psoriasis and obesity [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/35\" class=\"abstract_t\">35</a>]. (See <a href=\"topic.htm?path=comorbid-disease-in-psoriasis#H3467075\" class=\"medical medical_review\">&quot;Comorbid disease in psoriasis&quot;, section on 'Obesity'</a> and <a href=\"topic.htm?path=comorbid-disease-in-psoriasis#H1025661\" class=\"medical medical_review\">&quot;Comorbid disease in psoriasis&quot;, section on 'Alcohol abuse'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Drugs </strong>&ndash;<strong> </strong>Multiple drugs are associated with worsening psoriasis or psoriasis-like drug eruptions (<a href=\"image.htm?imageKey=DERM%2F99889\" class=\"graphic graphic_table graphicRef99889 \">table 1</a>). The most common offenders are beta blockers, <a href=\"topic.htm?path=lithium-drug-information\" class=\"drug drug_general\">lithium</a>, and antimalarial drugs. Paradoxically, TNF inhibitors, drugs used for the treatment of psoriasis, are occasionally linked to the development of psoriasis-like eruptions in patients treated with TNF inhibitors for other diseases [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/39-41\" class=\"abstract_t\">39-41</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Infections </strong>&ndash; Infections, both bacterial and viral, also may be associated with worsening of psoriasis. Poststreptococcal flares of guttate psoriasis and the onset or worsening of psoriasis in association with human immunodeficiency virus (HIV) infection are well-recognized contributors. (See <a href=\"topic.htm?path=guttate-psoriasis#H2500010\" class=\"medical medical_review\">&quot;Guttate psoriasis&quot;, section on 'Streptococcal infection'</a> and <a href=\"#H28371183\" class=\"local\">'HIV-infected patients'</a> below.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Alcohol </strong>&ndash; Alcohol consumption has been linked to psoriasis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/42,43\" class=\"abstract_t\">42,43</a>]. Alcohol abuse occurs with increased frequency in patients with psoriasis, and alcohol use may be associated with risk for the development or worsening of psoriasis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/44\" class=\"abstract_t\">44</a>]. Furthermore, in a population-based study, alcoholism was a significant risk factor for mortality among patients with psoriasis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/45\" class=\"abstract_t\">45</a>]. </p><p/><p class=\"bulletIndent1\">Alcohol consumption decreases the response to conventional psoriasis treatment [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/46\" class=\"abstract_t\">46</a>], perhaps due to decreased adherence. Moreover, alcohol consumption and psoriasis itself have been linked to an increased hepatic toxicity of <a href=\"topic.htm?path=methotrexate-drug-information\" class=\"drug drug_general\">methotrexate</a>, an important therapeutic option in the treatment of extensive psoriasis. (See <a href=\"topic.htm?path=comorbid-disease-in-psoriasis#H1025661\" class=\"medical medical_review\">&quot;Comorbid disease in psoriasis&quot;, section on 'Alcohol abuse'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Vitamin D deficiency </strong>&ndash; Vitamin D deficiency may be associated with increased risk for certain immune diseases, including type 1 diabetes, multiple sclerosis, and inflammatory bowel disease. The role of vitamin D status in psoriasis is uncertain. A case-control study that compared 43 patients with psoriasis and 43 matched controls with other non-photosensitive dermatologic diseases found that serum levels of 25-hydroxyvitamin D were lower in the patients with psoriasis even after adjusting for factors such as Fitzpatrick skin phototype (<a href=\"image.htm?imageKey=PC%2F60541\" class=\"graphic graphic_table graphicRef60541 \">table 2</a>) and estimated sun exposure [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/47\" class=\"abstract_t\">47</a>]. (See <a href=\"topic.htm?path=vitamin-d-and-extraskeletal-health#H651669\" class=\"medical medical_review\">&quot;Vitamin D and extraskeletal health&quot;, section on 'Immune system'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H28372191\"><span class=\"h1\">PATHOPHYSIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Historically, psoriasis was viewed as primarily a disease of hyperproliferation; however, it is now known that psoriasis is a complex immune-mediated disease in which T-lymphocytes and dendritic cells play a central role. The role of the immune system in psoriasis is discussed in greater detail separately. (See <a href=\"topic.htm?path=pathophysiology-of-psoriasis\" class=\"medical medical_review\">&quot;Pathophysiology of psoriasis&quot;</a>.)</p><p>The typical clinical findings of scaling, induration, and erythema are the result of hyperproliferation and abnormal differentiation of the epidermis, inflammatory cell infiltrates, and vascular dilatation. When compared with normal epidermis, this hyperproliferative state is characterized by:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Increased numbers of epidermal stem cells</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Increased numbers of cells undergoing DNA synthesis</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A shortened cell cycle time for keratinocytes (36 hours compared with 311 hours in normal skin)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A decreased turnover time of the epidermis (four days from basal cell layer to stratum corneum, compared with 27 days in normal skin)</p><p/><p>Abnormal differentiation in psoriatic skin is evidenced by a delay in the expression of keratins 1 and 10 (seen in normal skin) and an overexpression of keratins 6 and 16 (seen in reactive and healing skin).</p><p>The body of evidence demonstrating the importance of the immune system in the pathogenesis of psoriasis is contributing to the development of new therapies for the disease. The availability of biologic agents that work through targeted interference with leukocytes and cytokines has revolutionized psoriasis therapy. In addition, new treatments are contributing to our understanding of the immune pathogenesis of the disease. (See <a href=\"topic.htm?path=pathophysiology-of-psoriasis\" class=\"medical medical_review\">&quot;Pathophysiology of psoriasis&quot;</a> and <a href=\"topic.htm?path=treatment-of-psoriasis-in-adults#H36\" class=\"medical medical_review\">&quot;Treatment of psoriasis in adults&quot;, section on 'Biologic agents'</a> and <a href=\"topic.htm?path=treatment-of-psoriasis-in-adults#H43\" class=\"medical medical_review\">&quot;Treatment of psoriasis in adults&quot;, section on 'Future therapies'</a>.)</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Psoriasis occurs in a variety of clinical forms. The major clinical categories include: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chronic plaque psoriasis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Guttate psoriasis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pustular psoriasis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Erythrodermic psoriasis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Inverse psoriasis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nail psoriasis</p><p/><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Chronic plaque psoriasis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Chronic plaque psoriasis is the most common variant of psoriasis. A population-based study of 1633 patients with adult-onset psoriasis and 357 patients with pediatric-onset psoriasis found that chronic plaque psoriasis accounted for 79 and 74 percent of cases of psoriasis, respectively [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/5\" class=\"abstract_t\">5</a>]. A questionnaire study of 3179 women and 646 men in the Nurses' Health Study (NHS) and Health Professionals Follow-up Study (HPFS) with physician-diagnosed&nbsp;psoriasis&nbsp;found that 55 to 60 percent reported plaque psoriasis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/48\" class=\"abstract_t\">48</a>].</p><p>Patients with chronic plaque type psoriasis usually present with symmetrically distributed cutaneous plaques (<a href=\"image.htm?imageKey=DERM%2F87343%7EDERM%2F54581%7EDERM%2F87443%7EDERM%2F87441%7EDERM%2F99437\" class=\"graphic graphic_picture graphicRef87343 graphicRef54581 graphicRef87443 graphicRef87441 graphicRef99437 \">picture 1A-E</a>). The scalp, extensor elbows, knees, and gluteal cleft are common sites for involvement. The extent of involvement can range from limited localized disease to involvement of the majority of the body surface area. Involvement of intertriginous areas (inverse psoriasis), the ear canal, umbilicus, palms, soles, or nails also may be present (<a href=\"image.htm?imageKey=DERM%2F99445%7EDERM%2F99446\" class=\"graphic graphic_picture graphicRef99445 graphicRef99446 \">picture 3A-B</a>). (See <a href=\"#H28373595\" class=\"local\">'Inverse psoriasis'</a> below and <a href=\"#H28373678\" class=\"local\">'Nail psoriasis'</a> below.)</p><p>Psoriasis plaques are erythematous with sharply defined margins that are raised above the surrounding normal skin (<a href=\"image.htm?imageKey=DERM%2F87343%7EDERM%2F54581%7EDERM%2F87443%7EDERM%2F87441%7EDERM%2F99437\" class=\"graphic graphic_picture graphicRef87343 graphicRef54581 graphicRef87443 graphicRef87441 graphicRef99437 \">picture 1A-E</a>). In patients with dark skin, postinflammatory hyperpigmentation may be a prominent feature. A thick silvery scale is usually present, although recent bathing may remove the scale, and applications of moisturizers may make the scale temporarily invisible. The plaques can range from less than 1 to more than 10 cm in diameter. The plaques may be asymptomatic, but pruritus is common. Palmoplantar psoriasis can be very painful due to fissure formation and can be physically disabling (<a href=\"image.htm?imageKey=DERM%2F93909%7EDERM%2F99481\" class=\"graphic graphic_picture graphicRef93909 graphicRef99481 \">picture 4A-B</a>).</p><p>The Koebner phenomenon, which describes the development of skin disease in sites of skin trauma, may occur in patients with chronic plaque psoriasis. </p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Guttate psoriasis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Guttate psoriasis is characterized by the abrupt appearance of multiple small psoriatic papules and plaques (<a href=\"image.htm?imageKey=DERM%2F55141%7EDERM%2F64836\" class=\"graphic graphic_picture graphicRef55141 graphicRef64836 \">picture 5A-B</a>). The papules and plaques of guttate psoriasis are usually less than 1 cm in diameter (giving rise to the name guttate, which means drop-like). The trunk and proximal extremities are the primary sites of involvement. (See <a href=\"topic.htm?path=guttate-psoriasis\" class=\"medical medical_review\">&quot;Guttate psoriasis&quot;</a>.)</p><p>Guttate psoriasis typically occurs as an acute eruption in a child or young adult with no previous history of psoriasis. Less commonly, a guttate psoriatic flare occurs in a patient with preexisting psoriasis. There is a strong association between recent infection (usually streptococcal pharyngitis) and guttate psoriasis. (See <a href=\"topic.htm?path=guttate-psoriasis#H2500010\" class=\"medical medical_review\">&quot;Guttate psoriasis&quot;, section on 'Streptococcal infection'</a>.)</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h2\">Pustular psoriasis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pustular psoriasis is a form of psoriasis that can have life-threatening complications. The most severe variant (the von Zumbusch type of generalized pustular psoriasis) presents with the acute onset of widespread erythema, scaling, and sheets of superficial pustules (<a href=\"image.htm?imageKey=DERM%2F95194%7EDERM%2F94790\" class=\"graphic graphic_picture graphicRef95194 graphicRef94790 \">picture 2B, 2E</a>). This form of psoriasis can be associated with malaise, fever, diarrhea, leukocytosis, and hypocalcemia. Renal, hepatic, or respiratory abnormalities and sepsis are potential complications. (See <a href=\"topic.htm?path=pustular-psoriasis-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Pustular psoriasis: Pathogenesis, clinical manifestations, and diagnosis&quot;</a>.)</p><p>Reported causes of pustular psoriasis include pregnancy (impetigo herpetiformis), infection, and the withdrawal of oral glucocorticoids. The term impetigo herpetiformis has been used to refer to pustular psoriasis of pregnancy. (See <a href=\"topic.htm?path=dermatoses-of-pregnancy#H52\" class=\"medical medical_review\">&quot;Dermatoses of pregnancy&quot;, section on 'Pustular psoriasis of pregnancy'</a> and <a href=\"topic.htm?path=pustular-psoriasis-pathogenesis-clinical-manifestations-and-diagnosis#H86559840\" class=\"medical medical_review\">&quot;Pustular psoriasis: Pathogenesis, clinical manifestations, and diagnosis&quot;, section on 'Precipitating factors'</a>.) </p><p>Acrodermatitis continua of Hallopeau is a localized version of pustular psoriasis in which disease involves the distal digits (<a href=\"image.htm?imageKey=DERM%2F69799\" class=\"graphic graphic_picture graphicRef69799 \">picture 2D</a>). The categorization of palmoplantar pustulosis as a localized form of pustular psoriasis or a distinct entity is controversial (<a href=\"image.htm?imageKey=DERM%2F62582%7EDERM%2F75404\" class=\"graphic graphic_picture graphicRef62582 graphicRef75404 \">picture 6A-B</a>). (See <a href=\"topic.htm?path=pustular-psoriasis-pathogenesis-clinical-manifestations-and-diagnosis#H187511644\" class=\"medical medical_review\">&quot;Pustular psoriasis: Pathogenesis, clinical manifestations, and diagnosis&quot;, section on 'Acrodermatitis continua of Hallopeau'</a> and <a href=\"topic.htm?path=palmoplantar-pustulosis-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Palmoplantar pustulosis: Epidemiology, clinical features, and diagnosis&quot;</a>.) </p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h2\">Erythrodermic psoriasis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Erythrodermic psoriasis is an uncommon manifestation that may be acute or chronic. It is characterized by generalized erythema and scaling from head to toe (<a href=\"image.htm?imageKey=PC%2F71225%7EDERM%2F99440\" class=\"graphic graphic_picture graphicRef71225 graphicRef99440 \">picture 2C, 2F</a>). Such patients are at high risk for complications related to loss of adequate barrier protection such as infection (including sepsis) and electrolyte abnormalities secondary to fluid loss [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/49\" class=\"abstract_t\">49</a>]. Inpatient management involving a dermatologist is frequently necessary. (See <a href=\"topic.htm?path=erythroderma-in-adults\" class=\"medical medical_review\">&quot;Erythroderma in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H28373595\"><span class=\"h2\">Inverse psoriasis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>&quot;Inverse psoriasis&quot; refers to a presentation involving the intertriginous areas, including the inguinal, perineal, genital, intergluteal, axillary, or inframammary regions (<a href=\"image.htm?imageKey=DERM%2F99438%7EDERM%2F99439%7EDERM%2F78531%7EDERM%2F76200%7EDERM%2F50615%7EDERM%2F62411\" class=\"graphic graphic_picture graphicRef99438 graphicRef99439 graphicRef78531 graphicRef76200 graphicRef50615 graphicRef62411 \">picture 2A, 2G-K</a>). This presentation is called &quot;inverse&quot; since it is the reverse of the typical presentation on extensor surfaces. This variant can easily be misdiagnosed as a fungal or bacterial infection since there is frequently no visible scaling.</p><p class=\"headingAnchor\" id=\"H28373678\"><span class=\"h2\">Nail psoriasis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nail psoriasis is most often noted after the onset of cutaneous disease, but also may occur concurrently or prior to the onset of cutaneous psoriasis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/50,51\" class=\"abstract_t\">50,51</a>]. Occasionally, nail involvement is the only manifestation of psoriasis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/51,52\" class=\"abstract_t\">51,52</a>]. </p><p>The presence of nail disease may be important diagnostically, often providing valuable supportive evidence of disease in difficult cases. Nail disease is more common in patients with psoriatic arthritis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/50,52,53\" class=\"abstract_t\">50,52,53</a>], and may be one of the strongest clinical predictors for concomitant psoriatic arthritis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/54\" class=\"abstract_t\">54</a>]. This finding is likely related to close proximity of the distal interphalangeal joints and the nail matrix. </p><p>The clinical manifestations of nail psoriasis are related to involvement of the nail matrix or nail bed. The typical nail abnormality associated with matrix disease is pitting, consisting of a few to multiple tiny pits scattered over the nail plate (<a href=\"image.htm?imageKey=DERM%2F70962\" class=\"graphic graphic_picture graphicRef70962 \">picture 7</a>). These changes produce friable areas of cornified nail plate that erode away with normal friction. Other nail matrix findings include leukonychia, red spots on the lunula, and crumbling of the nail plate. </p><p>When the nail bed is involved, a localized color change in the nail may occur that resembles the tan-brown color of new motor oil, the &quot;oil drop sign&quot; (<a href=\"image.htm?imageKey=DERM%2F66374\" class=\"graphic graphic_picture graphicRef66374 \">picture 8</a>). Other nail bed findings reported to occur in patients with psoriasis include onycholysis, subungual hyperkeratosis, and splinter hemorrhages. [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/50,51,53\" class=\"abstract_t\">50,51,53</a>]. Subungual hyperkeratosis and nail plate thickening can be confused with onychomycosis (<a href=\"image.htm?imageKey=DERM%2F53509\" class=\"graphic graphic_picture graphicRef53509 \">picture 9</a>). </p><p>Nail psoriasis is reviewed in detail separately. (See <a href=\"topic.htm?path=nail-psoriasis\" class=\"medical medical_review\">&quot;Nail psoriasis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H28371219\"><span class=\"h1\">SPECIAL POPULATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In addition, psoriasis may occur more frequently and become more severe in certain populations, such as those with HIV infection. </p><p class=\"headingAnchor\" id=\"H28371183\"><span class=\"h2\">HIV-infected patients</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Psoriasis may be the presenting sign of human immunodeficiency virus (HIV) infection, or it can develop after the diagnosis has been made. Psoriasis associated with HIV infection frequently is severe, with palmar and plantar involvement, nail disease, arthritis, and widespread, nearly erythrodermic disease (<a href=\"image.htm?imageKey=DERM%2F99440\" class=\"graphic graphic_picture graphicRef99440 \">picture 2C</a>). Considerable overlap between HIV-associated psoriasis, psoriatic arthritis with HLA-B27 positivity, and reactive arthritis has led some authors to view these entities as a disease continuum [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/55\" class=\"abstract_t\">55</a>]. (See <a href=\"topic.htm?path=pathogenesis-of-spondyloarthritis\" class=\"medical medical_review\">&quot;Pathogenesis of spondyloarthritis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H28371232\"><span class=\"h2\">Children</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although psoriasis in adults and children can present similarly, there are also unique features in the pediatric population. (See <a href=\"topic.htm?path=psoriasis-in-children-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Psoriasis in children: Epidemiology, clinical manifestations, and diagnosis&quot;</a>.)</p><p>Psoriasis in infants often presents with involvement of the diaper area. The terms diaper psoriasis and napkin psoriasis are often used to refer to this presentation. Infants with diaper-area involvement typically develop symmetrical, well-demarcated erythematous patches with little scale (<a href=\"image.htm?imageKey=DERM%2F99441%7EDERM%2F99442\" class=\"graphic graphic_picture graphicRef99441 graphicRef99442 \">picture 10A-B</a>). Maceration may be present. Unlike irritant diaper dermatitis, the inguinal folds are usually involved. Affected infants may also have psoriatic plaques in other body areas. These plaques are often smaller and thinner than the psoriatic plaques in adult patients [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/56\" class=\"abstract_t\">56</a>]. (See <a href=\"topic.htm?path=psoriasis-in-children-epidemiology-clinical-manifestations-and-diagnosis#H1333717660\" class=\"medical medical_review\">&quot;Psoriasis in children: Epidemiology, clinical manifestations, and diagnosis&quot;, section on 'Special sites'</a>.)</p><p>The frequencies of specific features of the subtypes of psoriasis are notable in children. Scalp involvement is a common and often initial presentation of chronic plaque psoriasis in children (<a href=\"image.htm?imageKey=DERM%2F99443\" class=\"graphic graphic_picture graphicRef99443 \">picture 11</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/57\" class=\"abstract_t\">57</a>]. In addition, children with chronic plaque psoriasis are more likely to have facial involvement than adults. The most common presentation of generalized pustular psoriasis in children is the annular pustular psoriasis variant [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/58\" class=\"abstract_t\">58</a>]. Patients with generalized annular pustular psoriasis develop a recurring subacute eruption of annular or figurate erythematous plaques with peripheral pustules and scale. (See <a href=\"topic.htm?path=psoriasis-in-children-epidemiology-clinical-manifestations-and-diagnosis#H2354675065\" class=\"medical medical_review\">&quot;Psoriasis in children: Epidemiology, clinical manifestations, and diagnosis&quot;, section on 'Clinical presentation'</a>.)</p><p class=\"headingAnchor\" id=\"H28371264\"><span class=\"h1\">ASSOCIATED DISORDERS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with psoriasis experience increased risk for certain joint, eye, and systemic disorders.</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h2\">Psoriatic arthritis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Psoriatic arthritis is one of several seronegative spondyloarthropathies that include ankylosing spondylitis and reactive arthritis. Psoriatic arthritis is common in patients with psoriasis, with reported prevalence estimates ranging from 7 to 48 percent [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/59-63\" class=\"abstract_t\">59-63</a>]. A European and North American multinational study in which 949 patients with psoriasis were evaluated by both dermatologists and rheumatologists found evidence of psoriatic arthritis in 285 patients (30 percent) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/63\" class=\"abstract_t\">63</a>]. When seeing patients with psoriasis, screening for psoriatic arthritis is recommended; screening questions can include asking about the presence of joint pain, joint stiffness (particularly morning stiffness), and back pain (which patients may not recognize as a manifestation of joint pain) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/64\" class=\"abstract_t\">64</a>].</p><p>Most patients with psoriatic arthritis have coincidental skin involvement, although arthritis precedes the skin disease in approximately 15 percent of cases. Nail involvement is common [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/50\" class=\"abstract_t\">50</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-psoriatic-arthritis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of psoriatic arthritis&quot;</a> and <a href=\"#H28373678\" class=\"local\">'Nail psoriasis'</a> above.)</p><p>Several clinical patterns of joint involvement in psoriatic arthritis have been identified [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/65\" class=\"abstract_t\">65</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Distal arthritis, characterized by involvement of the distal interphalangeal (DIP) joints (<a href=\"image.htm?imageKey=RHEUM%2F70503\" class=\"graphic graphic_picture graphicRef70503 \">picture 12</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Asymmetric oligoarthritis in which less than five small <span class=\"nowrap\">and/or</span> large joints are affected in an asymmetric distribution</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Symmetric polyarthritis, similar and at times indistinguishable from rheumatoid arthritis</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Arthritis mutilans, characterized by deforming and destructive arthritis (<a href=\"image.htm?imageKey=RHEUM%2F51683\" class=\"graphic graphic_picture graphicRef51683 \">picture 13</a> and <a href=\"image.htm?imageKey=RHEUM%2F58184\" class=\"graphic graphic_diagnosticimage graphicRef58184 \">image 1</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Spondyloarthropathy, including both sacroiliitis and spondylitis</p><p/><p>Soft tissue inflammation manifesting as enthesitis (inflammation at the site of tendon insertion into bone), tenosynovitis, and dactylitis (&quot;sausage digits&quot;) are additional common findings in psoriatic arthritis. Psoriatic arthritis is discussed in greater detail separately. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-psoriatic-arthritis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of psoriatic arthritis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H28371361\"><span class=\"h2\">Systemic disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although psoriasis is primarily a disease of the skin, there is an increasing understanding of the prevalence of comorbid conditions in patients with psoriasis. </p><p>Examples of diseases reported to occur at a higher frequency in patients with psoriasis include cardiovascular disease, malignancy, diabetes, hypertension, metabolic syndrome, inflammatory bowel disease, serious infections, and autoimmune disorders [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/66-76\" class=\"abstract_t\">66-76</a>]. The reasons for these associations are not well understood. Examples of factors that may contribute to the occurrence of comorbid disease in patients with psoriasis include the effects of immune-mediated chronic inflammation, lifestyle factors, and the adverse effects of systemic therapies. The comorbidities of psoriasis are reviewed separately. (See <a href=\"topic.htm?path=comorbid-disease-in-psoriasis\" class=\"medical medical_review\">&quot;Comorbid disease in psoriasis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H28371920\"><span class=\"h2\">Ocular findings</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Disorders of the eye, such as blepharitis, conjunctivitis, xerosis, corneal lesions, and uveitis may occur with increased frequency in patients with psoriasis. Symptoms of eye involvement include ocular discomfort, flaking or crusting within the eyelashes, swollen eyelids, red eyes, visual changes, and psoriatic lesions on the lids or lid margins [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/77\" class=\"abstract_t\">77</a>]. </p><p>The proportion of patients with psoriasis and ocular disorders is not definitively known, and guidelines for screening for ocular involvement in patients with psoriasis have not been established. Asking patients about ocular symptoms at each follow-up visit may help to identify patients with ocular involvement. In addition, some authors have suggested routine ophthalmic examinations every one to two years in patients with severe psoriasis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/77\" class=\"abstract_t\">77</a>].</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h1\">CLINICAL COURSE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A given patient's course of psoriasis is unpredictable. Plaque psoriasis, the most common presentation of psoriasis, tends to be a chronic disease [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/78\" class=\"abstract_t\">78</a>]. However, there may be marked variability in severity over time [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/79\" class=\"abstract_t\">79</a>]. Guttate psoriasis may spontaneously remit, recur, or progress into chronic plaque psoriasis. Generalized pustular psoriasis often runs an unstable and prolonged course without treatment. (See <a href=\"topic.htm?path=guttate-psoriasis#H2501744\" class=\"medical medical_review\">&quot;Guttate psoriasis&quot;, section on 'Clinical course'</a> and <a href=\"topic.htm?path=pustular-psoriasis-pathogenesis-clinical-manifestations-and-diagnosis#H251419367\" class=\"medical medical_review\">&quot;Pustular psoriasis: Pathogenesis, clinical manifestations, and diagnosis&quot;, section on 'Clinical course'</a>.)</p><p>Psoriasis is a rare cause of mortality (eg, with widespread pustular or erythrodermic psoriasis), but there were at least a few dozen deaths due to psoriasis in the United States annually before the introduction of biologic medications [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/80\" class=\"abstract_t\">80</a>]. In addition to mortality from severe disease, psoriasis is associated with increased overall mortality [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/81\" class=\"abstract_t\">81</a>]. Some deaths may be due to adverse effects from systemic therapies. Psoriasis may contribute to more deaths through an increased risk of comorbid cardiovascular disease. (See <a href=\"topic.htm?path=pustular-psoriasis-pathogenesis-clinical-manifestations-and-diagnosis#H251419367\" class=\"medical medical_review\">&quot;Pustular psoriasis: Pathogenesis, clinical manifestations, and diagnosis&quot;, section on 'Clinical course'</a> and <a href=\"topic.htm?path=comorbid-disease-in-psoriasis\" class=\"medical medical_review\">&quot;Comorbid disease in psoriasis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H28372119\"><span class=\"h1\">HISTOPATHOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Classic histologic findings of psoriasis include epidermal hyperplasia that is regular or uniform in degree, parakeratosis (retention of nuclei in the stratum corneum), neutrophils in the stratum corneum and epidermis, a thinned or absent granular cell layer of the epidermis, thinning of the suprapapillary dermal plates, and tortuous dilated dermal papillary capillaries. Microabscesses of neutrophils may be present in the stratum corneum. Similar histologic features may be present in superficial fungal skin infections.</p><p>Early lesions differ from established plaques and may only possess superficial perivascular lymphocytic infiltrates and dilated tortuous capillaries. Additionally, atypical cases and partially treated cases of psoriasis can have histologic findings that are suggestive but not diagnostic.</p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although the differential diagnosis of psoriasis is broad, a diagnosis of psoriasis can be made by history and physical examination in the vast majority of cases. Suspicion for chronic plaque psoriasis should arise when patients present with well-demarcated inflamed cutaneous plaques with overlying coarse scale.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>History and physical examination </strong>&ndash; A full skin examination that includes examination of the scalp, nails, and anogenital skin should be offered to patients with suspected chronic plaque psoriasis. Examination findings that support the diagnosis include the classic well-demarcated plaques and coarse scale, particularly when involvement of the scalp, ears, elbows, knees, umbilicus, or nails is present. Other characteristics supportive of plaque psoriasis include a positive family history, recognition of concomitant inverse psoriasis in the intergluteal cleft or other sites, and evidence of the Koebner phenomenon. The Auspitz sign, which refers to the visualization of pinpoint bleeding after removal of scale overlying a psoriatic plaque, is an additional common clinical finding, but does not definitively confirm or exclude the diagnosis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/82\" class=\"abstract_t\">82</a>]. The patient's medications also should be reviewed to evaluate for drugs that may contribute to psoriasis. (See <a href=\"#H28373348\" class=\"local\">'Other factors'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Laboratory studies </strong>&ndash; Occasionally, a skin biopsy is performed to rule out other conditions. When biopsy is necessary (eg, when the clinical examination is insufficient to make the diagnosis), a 4 mm punch biopsy from involved skin is recommended, though a shave biopsy through the mid-dermis may also be adequate. A Periodic acid&ndash;Schiff&ndash;diastase (PAS-D) stain of the specimen may help distinguish psoriasis from a superficial fungal infection. There are no other laboratory tests that confirm or exclude the diagnosis. (See <a href=\"topic.htm?path=skin-biopsy-techniques#H12\" class=\"medical medical_review\">&quot;Skin biopsy techniques&quot;, section on 'Punch biopsy'</a>.)</p><p/><p>In addition to the evaluation above, patients diagnosed with psoriasis should be assessed for signs or symptoms of psoriatic arthritis and other comorbidities. (See <a href=\"#H17\" class=\"local\">'Psoriatic arthritis'</a> above and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-psoriatic-arthritis#H6558497\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of psoriatic arthritis&quot;, section on 'Diagnosis'</a> and <a href=\"topic.htm?path=comorbid-disease-in-psoriasis#H3467131\" class=\"medical medical_review\">&quot;Comorbid disease in psoriasis&quot;, section on 'Evaluation and management'</a>.)</p><p>The diagnostic approach to guttate psoriasis, pustular psoriasis, and erythrodermic psoriasis is reviewed separately. (See <a href=\"topic.htm?path=guttate-psoriasis#H1391875279\" class=\"medical medical_review\">&quot;Guttate psoriasis&quot;, section on 'Diagnosis'</a> and <a href=\"topic.htm?path=pustular-psoriasis-pathogenesis-clinical-manifestations-and-diagnosis#H506198858\" class=\"medical medical_review\">&quot;Pustular psoriasis: Pathogenesis, clinical manifestations, and diagnosis&quot;, section on 'Diagnosis'</a> and <a href=\"topic.htm?path=erythroderma-in-adults#H5244967\" class=\"medical medical_review\">&quot;Erythroderma in adults&quot;, section on 'Determination of underlying cause'</a>.)</p><p class=\"headingAnchor\" id=\"H28371285\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of psoriasis varies according to the clinical presentation. Chronic plaque psoriasis should be distinguished from a variety of dermatitic conditions. Key disorders that may be mistaken for psoriasis include seborrheic dermatitis, lichen simplex chronicus, atopic dermatitis, and nummular eczema.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Seborrheic dermatitis </strong>&ndash; Seborrheic dermatitis usually presents with erythematous patches with overlying scale (<a href=\"image.htm?imageKey=DERM%2F56410%7EDERM%2F53407%7EDERM%2F76985\" class=\"graphic graphic_picture graphicRef56410 graphicRef53407 graphicRef76985 \">picture 14A-C</a>). In individuals with dark skin, the erythema may be less visible (<a href=\"image.htm?imageKey=DERM%2F53407%7EDERM%2F65167\" class=\"graphic graphic_picture graphicRef53407 graphicRef65167 \">picture 14B, 14D</a>). Both psoriasis and seborrheic dermatitis commonly involve the scalp, ears, and intertriginous areas. Features that support a diagnosis of seborrheic dermatitis include the characteristic fine, greasy scale typically evident in non-intertriginous locations and involvement of classic areas such as the eyebrows, nasolabial folds, central chest, or postauricular area. The presence of nail changes or characteristic changes of psoriasis in other areas helps distinguish psoriasis from seborrheic dermatitis. (See <a href=\"topic.htm?path=seborrheic-dermatitis-in-adolescents-and-adults\" class=\"medical medical_review\">&quot;Seborrheic dermatitis in adolescents and adults&quot;</a> and <a href=\"topic.htm?path=cradle-cap-and-seborrheic-dermatitis-in-infants\" class=\"medical medical_review\">&quot;Cradle cap and seborrheic dermatitis in infants&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Lichen simplex chronicus </strong>&ndash; Lichen simplex chronicus describes skin changes that occur secondary to excessive scratching of the skin. An underlying cause of pruritus or scratching (eg, atopic dermatitis, arthropod bite, or psychological disorder) is often present. Patients develop plaques of thickened skin that exhibit accentuated skin markings (<a href=\"image.htm?imageKey=DERM%2F73843\" class=\"graphic graphic_picture graphicRef73843 \">picture 15</a>). Overlying scale or hyperpigmentation may be present. Sites where the patient cannot reach are unaffected. Lichen simplex chronicus can occur in combination with psoriasis when psoriasis lesions are very itchy.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Atopic dermatitis </strong>&ndash; Atopic dermatitis is a common skin disorder associated with the development of pruritus and often excoriated papules and patches that may exhibit erythema, hyperpigmentation, or scale (<a href=\"image.htm?imageKey=DERM%2F64525%7EDERM%2F55375\" class=\"graphic graphic_picture graphicRef64525 graphicRef55375 \">picture 16A-B</a>). Localized areas of skin lichenification (thickening) are common. The characteristic thick, coarse scale and sharp, raised, well-defined borders of psoriasis are typically absent. In older children and adults, atopic dermatitis tends to involve skin flexures. Infants often have facial or scalp involvement (<a href=\"image.htm?imageKey=ALLRG%2F56461\" class=\"graphic graphic_picture graphicRef56461 \">picture 17</a>). Unlike psoriasis, the diaper area is classically spared. (See <a href=\"topic.htm?path=atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Nummular eczema </strong>&ndash; Nummular eczema (also known as nummular dermatitis) typically presents with well-demarcated, round plaques 1 to 10 cm in diameter (<a href=\"image.htm?imageKey=DERM%2F96164%7EDERM%2F58067\" class=\"graphic graphic_picture graphicRef96164 graphicRef58067 \">picture 18A-B</a>). The plaques are often erythematous with overlying scale, crust, or small fissures and have indistinct borders (like atopic dermatitis but unlike psoriasis). The trunk and extremities are the usual sites of involvement. The face and scalp are spared. (See <a href=\"topic.htm?path=nummular-eczema\" class=\"medical medical_review\">&quot;Nummular eczema&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Superficial fungal infections </strong>&ndash; Superficial fungal infections (eg, tinea corporis, tinea pedis, cutaneous candidiasis) may present with erythematous plaques (with or without pustules) that may be mistaken for psoriasis (<a href=\"image.htm?imageKey=DERM%2F99892%7EDERM%2F99894\" class=\"graphic graphic_picture graphicRef99892 graphicRef99894 \">picture 19A-B</a>). Nail changes related to onychomycosis can also be confused with nail psoriasis (<a href=\"image.htm?imageKey=DERM%2F85579\" class=\"graphic graphic_picture graphicRef85579 \">picture 20</a>). A potassium hydroxide (KOH) preparation is useful for confirming fungal infection. (See <a href=\"topic.htm?path=dermatophyte-tinea-infections\" class=\"medical medical_review\">&quot;Dermatophyte (tinea) infections&quot;</a> and <a href=\"topic.htm?path=onychomycosis-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Onychomycosis: Epidemiology, clinical features, and diagnosis&quot;</a>.)</p><p/><p>Other less common disorders that should be considered in the differential diagnosis of chronic plaque psoriasis include subacute cutaneous lupus erythematosus, pityriasis rubra pilaris, crusted scabies, and cutaneous T cell lymphoma. </p><p>The disorders in the differential diagnosis of guttate psoriasis and pustular psoriasis are reviewed separately. (See <a href=\"topic.htm?path=guttate-psoriasis#H2500104\" class=\"medical medical_review\">&quot;Guttate psoriasis&quot;, section on 'Differential diagnosis'</a> and <a href=\"topic.htm?path=pustular-psoriasis-pathogenesis-clinical-manifestations-and-diagnosis#H506198876\" class=\"medical medical_review\">&quot;Pustular psoriasis: Pathogenesis, clinical manifestations, and diagnosis&quot;, section on 'Differential diagnosis'</a>.)</p><p>Erythrodermic psoriasis should be distinguished from other causes of erythroderma. (See <a href=\"topic.htm?path=erythroderma-in-adults#H12240285\" class=\"medical medical_review\">&quot;Erythroderma in adults&quot;, section on 'Etiology'</a> and <a href=\"topic.htm?path=erythroderma-in-adults#H5244967\" class=\"medical medical_review\">&quot;Erythroderma in adults&quot;, section on 'Determination of underlying cause'</a>.)</p><p class=\"headingAnchor\" id=\"H1630212384\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-psoriasis\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Psoriasis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=psoriasis-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Psoriasis (The Basics)&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Beyond the Basics topics (see <a href=\"topic.htm?path=psoriasis-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Psoriasis (Beyond the Basics)&quot;</a> and <a href=\"topic.htm?path=psoriatic-arthritis-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Psoriatic arthritis (Beyond the Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H25\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Psoriasis is a common disorder that affects men and women equally. Although psoriasis can begin at any age, the peak times for disease onset are ages 30 to 39 and ages 50 to 69 years. (See <a href=\"#H2\" class=\"local\">'Epidemiology'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Psoriasis is a complex immune-mediated disease. Genetic factors play an important role in susceptibility to psoriasis. The psoriasis-susceptibility (PSORS1) locus within the major histocompatibility complex (MHC) on chromosome 6p21 is considered a major genetic determinant of this disease, but many other genes play a role. (See <a href=\"#H28372191\" class=\"local\">'Pathophysiology'</a> above and <a href=\"topic.htm?path=pathophysiology-of-psoriasis\" class=\"medical medical_review\">&quot;Pathophysiology of psoriasis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>There are multiple clinical subtypes of psoriasis. Chronic plaque psoriasis, the most common presentation of psoriasis, most commonly presents with sharply defined erythematous plaques with overlying silvery scale (<a href=\"image.htm?imageKey=DERM%2F87343%7EDERM%2F54581%7EDERM%2F87443%7EDERM%2F87441%7EDERM%2F99437\" class=\"graphic graphic_picture graphicRef87343 graphicRef54581 graphicRef87443 graphicRef87441 graphicRef99437 \">picture 1A-E</a>). The scalp, extensor elbows, knees, and gluteal cleft are common locations for plaque psoriasis. (See <a href=\"#H9\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Psoriasis has been associated with multiple comorbidities. Approximately 30 percent of patients have psoriatic arthritis. Psoriasis has also been associated with cardiovascular disease and other systemic diseases. (See <a href=\"#H28371361\" class=\"local\">'Systemic disease'</a> above and <a href=\"topic.htm?path=comorbid-disease-in-psoriasis\" class=\"medical medical_review\">&quot;Comorbid disease in psoriasis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A diagnosis of psoriasis can be made by history and physical examination in the vast majority of cases. Occasionally, a skin biopsy is needed to rule out other conditions. (See <a href=\"#H23\" class=\"local\">'Diagnosis'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/1\" class=\"nounderline abstract_t\">Parisi R, Symmons DP, Griffiths CE, et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 2013; 133:377.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/2\" class=\"nounderline abstract_t\">Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol 2017; 31:205.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/3\" class=\"nounderline abstract_t\">Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol 2014; 70:512.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/4\" class=\"nounderline abstract_t\">Icen M, Crowson CS, McEvoy MT, et al. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol 2009; 60:394.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/5\" class=\"nounderline abstract_t\">Tollefson MM, Crowson CS, McEvoy MT, Maradit Kremers H. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol 2010; 62:979.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/6\" class=\"nounderline abstract_t\">Gladman DD, Anhorn KA, Schachter RK, Mervart H. HLA antigens in psoriatic arthritis. J Rheumatol 1986; 13:586.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/7\" class=\"nounderline abstract_t\">Farber EM, Nall ML, Watson W. Natural history of psoriasis in 61 twin pairs. Arch Dermatol 1974; 109:207.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/8\" class=\"nounderline abstract_t\">Duffy DL, Spelman LS, Martin NG. Psoriasis in Australian twins. J Am Acad Dermatol 1993; 29:428.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/9\" class=\"nounderline abstract_t\">Brandrup F, Holm N, Grunnet N, et al. Psoriasis in monozygotic twins: variations in expression in individuals with identical genetic constitution. Acta Derm Venereol 1982; 62:229.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/10\" class=\"nounderline abstract_t\">Genetic Analysis of Psoriasis Consortium &amp; the Wellcome Trust Case Control Consortium 2, Strange A, Capon F, et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 2010; 42:985.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/11\" class=\"nounderline abstract_t\">Ellinghaus E, Ellinghaus D, Stuart PE, et al. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat Genet 2010; 42:991.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/12\" class=\"nounderline abstract_t\">H&uuml;ffmeier U, Uebe S, Ekici AB, et al. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat Genet 2010; 42:996.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/13\" class=\"nounderline abstract_t\">Stuart PE, Nair RP, Ellinghaus E, et al. Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat Genet 2010; 42:1000.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/14\" class=\"nounderline abstract_t\">Tsoi LC, Spain SL, Knight J, et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 2012; 44:1341.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/15\" class=\"nounderline abstract_t\">Nair RP, Duffin KC, Helms C, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 2009; 41:199.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/16\" class=\"nounderline abstract_t\">Mahil SK, Capon F, Barker JN. Genetics of psoriasis. Dermatol Clin 2015; 33:1.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/17\" class=\"nounderline abstract_t\">Trembath RC, Clough RL, Rosbotham JL, et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 1997; 6:813.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/18\" class=\"nounderline abstract_t\">Sagoo GS, Tazi-Ahnini R, Barker JW, et al. Meta-analysis of genome-wide studies of psoriasis susceptibility reveals linkage to chromosomes 6p21 and 4q28-q31 in Caucasian and Chinese Hans population. J Invest Dermatol 2004; 122:1401.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/19\" class=\"nounderline abstract_t\">Mallon E, Bunce M, Wojnarowska F, Welsh K. HLA-CW*0602 is a susceptibility factor in type I psoriasis, and evidence Ala-73 is increased in male type I psoriatics. J Invest Dermatol 1997; 109:183.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/20\" class=\"nounderline abstract_t\">Nair RP, Stuart PE, Nistor I, et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet 2006; 78:827.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/21\" class=\"nounderline abstract_t\">Alenius GM, Jidell E, Nordmark L, Rantap&auml;&auml; Dahlqvist S. Disease manifestations and HLA antigens in psoriatic arthritis in northern Sweden. Clin Rheumatol 2002; 21:357.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/22\" class=\"nounderline abstract_t\">Cargill M, Schrodi SJ, Chang M, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007; 80:273.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/23\" class=\"nounderline abstract_t\">Garcia VE, Chang M, Brandon R, et al. Detailed genetic characterization of the interleukin-23 receptor in psoriasis. Genes Immun 2008; 9:546.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/24\" class=\"nounderline abstract_t\">Hollox EJ, Huffmeier U, Zeeuwen PL, et al. Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 2008; 40:23.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/25\" class=\"nounderline abstract_t\">H&eacute;bert HL, Bowes J, Smith RL, et al. Polymorphisms in IL-1B distinguish between psoriasis of early and late onset. J Invest Dermatol 2014; 134:1459.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/26\" class=\"nounderline abstract_t\">Zhang XJ, Huang W, Yang S, et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet 2009; 41:205.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/27\" class=\"nounderline abstract_t\">de Cid R, Riveira-Munoz E, Zeeuwen PL, et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 2009; 41:211.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/28\" class=\"nounderline abstract_t\">Armstrong AW, Harskamp CT, Dhillon JS, Armstrong EJ. Psoriasis and smoking: a systematic review and meta-analysis. Br J Dermatol 2014; 170:304.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/29\" class=\"nounderline abstract_t\">Li W, Han J, Choi HK, Qureshi AA. Smoking and risk of incident psoriasis among women and men in the United States: a combined analysis. Am J Epidemiol 2012; 175:402.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/30\" class=\"nounderline abstract_t\">Eriksson MO, Hagforsen E, Lundin IP, Micha&euml;lsson G. Palmoplantar pustulosis: a clinical and immunohistological study. Br J Dermatol 1998; 138:390.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/31\" class=\"nounderline abstract_t\">Micha&euml;lsson G, Gustafsson K, Hagforsen E. The psoriasis variant palmoplantar pustulosis can be improved after cessation of smoking. J Am Acad Dermatol 2006; 54:737.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/32\" class=\"nounderline abstract_t\">Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32:982.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/33\" class=\"nounderline abstract_t\">McGowan JW, Pearce DJ, Chen J, et al. The skinny on psoriasis and obesity. Arch Dermatol 2005; 141:1601.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/34\" class=\"nounderline abstract_t\">Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med 2007; 167:1670.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/35\" class=\"nounderline abstract_t\">Bremmer S, Van Voorhees AS, Hsu S, et al. Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol 2010; 63:1058.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/36\" class=\"nounderline abstract_t\">Koebnick C, Black MH, Smith N, et al. The association of psoriasis and elevated blood lipids in overweight and obese children. J Pediatr 2011; 159:577.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/37\" class=\"nounderline abstract_t\">Augustin M, Glaeske G, Radtke MA, et al. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 2010; 162:633.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/38\" class=\"nounderline abstract_t\">Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies. Nutr Diabetes 2012; 2:e54.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/39\" class=\"nounderline abstract_t\">Cullen G, Kroshinsky D, Cheifetz AS, Korzenik JR. Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature. Aliment Pharmacol Ther 2011; 34:1318.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/40\" class=\"nounderline abstract_t\">Pugliese D, Guidi L, Ferraro PM, et al. Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study. Aliment Pharmacol Ther 2015; 42:880.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/41\" class=\"nounderline abstract_t\">Eickstaedt JB, Killpack L, Tung J, et al. Psoriasis and Psoriasiform Eruptions in Pediatric Patients with Inflammatory Bowel Disease Treated with Anti-Tumor Necrosis Factor Alpha Agents. Pediatr Dermatol 2017; 34:253.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/42\" class=\"nounderline abstract_t\">Higgins E. Alcohol, smoking and psoriasis. Clin Exp Dermatol 2000; 25:107.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/43\" class=\"nounderline abstract_t\">Qureshi AA, Dominguez PL, Choi HK, et al. Alcohol intake and risk of incident psoriasis in US women: a prospective study. Arch Dermatol 2010; 146:1364.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/44\" class=\"nounderline abstract_t\">Murzaku EC, Bronsnick T, Rao BK. Diet in dermatology: Part II. Melanoma, chronic urticaria, and psoriasis. J Am Acad Dermatol 2014; 71:1053.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/45\" class=\"nounderline abstract_t\">Poikolainen K, Karvonen J, Pukkala E. Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol 1999; 135:1490.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/46\" class=\"nounderline abstract_t\">Gupta MA, Schork NJ, Gupta AK, Ellis CN. Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol 1993; 28:730.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/47\" class=\"nounderline abstract_t\">Orgaz-Molina J, Buend&iacute;a-Eisman A, Arrabal-Polo MA, et al. Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study. J Am Acad Dermatol 2012; 67:931.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/48\" class=\"nounderline abstract_t\">Merola JF, Li T, Li WQ, et al. Prevalence of psoriasis phenotypes among men and women in the USA. Clin Exp Dermatol 2016; 41:486.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/49\" class=\"nounderline abstract_t\">Boyd AS, Menter A. Erythrodermic psoriasis. Precipitating factors, course, and prognosis in 50 patients. J Am Acad Dermatol 1989; 21:985.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/50\" class=\"nounderline abstract_t\">Klaassen KM, van de Kerkhof PC, Pasch MC. Nail psoriasis: a questionnaire-based survey. Br J Dermatol 2013; 169:314.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/51\" class=\"nounderline abstract_t\">van der Velden HM, Klaassen KM, van de Kerkhof PC, Pasch MC. Fingernail psoriasis reconsidered: a case-control study. J Am Acad Dermatol 2013; 69:245.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/52\" class=\"nounderline abstract_t\">Grover C, Reddy BS, Uma Chaturvedi K. Diagnosis of nail psoriasis: importance of biopsy and histopathology. Br J Dermatol 2005; 153:1153.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/53\" class=\"nounderline abstract_t\">Brazzelli V, Carugno A, Alborghetti A, et al. Prevalence, severity and clinical features of psoriasis in fingernails and toenails in adult patients: Italian experience. J Eur Acad Dermatol Venereol 2012; 26:1354.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/54\" class=\"nounderline abstract_t\">Langenbruch A, Radtke MA, Krensel M, et al. Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis. Br J Dermatol 2014; 171:1123.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/55\" class=\"nounderline abstract_t\">Reveille JD, Conant MA, Duvic M. Human immunodeficiency virus-associated psoriasis, psoriatic arthritis, and Reiter's syndrome: a disease continuum? Arthritis Rheum 1990; 33:1574.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/56\" class=\"nounderline abstract_t\">Tollefson MM. Diagnosis and management of psoriasis in children. Pediatr Clin North Am 2014; 61:261.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/57\" class=\"nounderline abstract_t\">Shah KN. Diagnosis and treatment of pediatric psoriasis: current and future. Am J Clin Dermatol 2013; 14:195.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/58\" class=\"nounderline abstract_t\">Liao PB, Rubinson R, Howard R, et al. Annular pustular psoriasis--most common form of pustular psoriasis in children: report of three cases and review of the literature. Pediatr Dermatol 2002; 19:19.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/59\" class=\"nounderline abstract_t\">Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005; 53:573.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/60\" class=\"nounderline abstract_t\">Reich K, Kr&uuml;ger K, M&ouml;ssner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 2009; 160:1040.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/61\" class=\"nounderline abstract_t\">Radtke MA, Reich K, Blome C, et al. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol 2009; 23:683.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/62\" class=\"nounderline abstract_t\">Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009; 61:1373.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/63\" class=\"nounderline abstract_t\">Mease PJ, Gladman DD, Papp KA, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol 2013; 69:729.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/64\" class=\"nounderline abstract_t\">Taylor SL, Petrie M, O'Rourke KS, Feldman SR. Rheumatologists' recommendations on what to do in the dermatology office to evaluate and manage psoriasis patients' joint symptoms. J Dermatolog Treat 2009; 20:350.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/65\" class=\"nounderline abstract_t\">Garg A, Gladman D. Recognizing psoriatic arthritis in the dermatology clinic. J Am Acad Dermatol 2010; 63:733.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/66\" class=\"nounderline abstract_t\">Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296:1735.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/67\" class=\"nounderline abstract_t\">Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007; 157:68.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/68\" class=\"nounderline abstract_t\">Neimann AL, Shin DB, Wang X, et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55:829.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/69\" class=\"nounderline abstract_t\">Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005; 129:827.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/70\" class=\"nounderline abstract_t\">Pearce DJ, Morrison AE, Higgins KB, et al. The comorbid state of psoriasis patients in a university dermatology practice. J Dermatolog Treat 2005; 16:319.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/71\" class=\"nounderline abstract_t\">Makredes M, Robinson D Jr, Bala M, Kimball AB. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis. J Am Acad Dermatol 2009; 61:405.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/72\" class=\"nounderline abstract_t\">Brauchli YB, Jick SS, Miret M, Meier CR. Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis. J Invest Dermatol 2009; 129:2604.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/73\" class=\"nounderline abstract_t\">Patel RV, Shelling ML, Prodanovich S, et al. Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature. J Gen Intern Med 2011; 26:1036.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/74\" class=\"nounderline abstract_t\">Qureshi AA, Choi HK, Setty AR, Curhan GC. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol 2009; 145:379.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/75\" class=\"nounderline abstract_t\">Wakkee M, de Vries E, van den Haak P, Nijsten T. Increased risk of infectious disease requiring hospitalization among patients with psoriasis: a population-based cohort. J Am Acad Dermatol 2011; 65:1135.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/76\" class=\"nounderline abstract_t\">Wu JJ, Nguyen TU, Poon KY, Herrinton LJ. The association of psoriasis with autoimmune diseases. J Am Acad Dermatol 2012; 67:924.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/77\" class=\"nounderline abstract_t\">Rehal B, Modjtahedi BS, Morse LS, et al. Ocular psoriasis. J Am Acad Dermatol 2011; 65:1202.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/78\" class=\"nounderline abstract_t\">Nijsten T, Looman CW, Stern RS. Clinical severity of psoriasis in last 20 years of PUVA study. Arch Dermatol 2007; 143:1113.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/79\" class=\"nounderline abstract_t\">Nevitt GJ, Hutchinson PE. Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease. Br J Dermatol 1996; 135:533.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/80\" class=\"nounderline abstract_t\">Pearce DJ, Lucas J, Wood B, et al. Death from psoriasis: representative US data. J Dermatolog Treat 2006; 17:302.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/81\" class=\"nounderline abstract_t\">Springate DA, Parisi R, Kontopantelis E, et al. Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study. Br J Dermatol 2017; 176:650.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis/abstract/82\" class=\"nounderline abstract_t\">Bernhard JD. Auspitz sign is not sensitive or specific for psoriasis. J Am Acad Dermatol 1990; 22:1079.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 5664 Version 32.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H25\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">RISK FACTORS</a><ul><li><a href=\"#H28372879\" id=\"outline-link-H28372879\">Genetic factors</a></li><li><a href=\"#H28373348\" id=\"outline-link-H28373348\">Other factors</a></li></ul></li><li><a href=\"#H28372191\" id=\"outline-link-H28372191\">PATHOPHYSIOLOGY</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H10\" id=\"outline-link-H10\">Chronic plaque psoriasis</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">Guttate psoriasis</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">Pustular psoriasis</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">Erythrodermic psoriasis</a></li><li><a href=\"#H28373595\" id=\"outline-link-H28373595\">Inverse psoriasis</a></li><li><a href=\"#H28373678\" id=\"outline-link-H28373678\">Nail psoriasis</a></li></ul></li><li><a href=\"#H28371219\" id=\"outline-link-H28371219\">SPECIAL POPULATIONS</a><ul><li><a href=\"#H28371183\" id=\"outline-link-H28371183\">HIV-infected patients</a></li><li><a href=\"#H28371232\" id=\"outline-link-H28371232\">Children</a></li></ul></li><li><a href=\"#H28371264\" id=\"outline-link-H28371264\">ASSOCIATED DISORDERS</a><ul><li><a href=\"#H17\" id=\"outline-link-H17\">Psoriatic arthritis</a></li><li><a href=\"#H28371361\" id=\"outline-link-H28371361\">Systemic disease</a></li><li><a href=\"#H28371920\" id=\"outline-link-H28371920\">Ocular findings</a></li></ul></li><li><a href=\"#H19\" id=\"outline-link-H19\">CLINICAL COURSE</a></li><li><a href=\"#H28372119\" id=\"outline-link-H28372119\">HISTOPATHOLOGY</a></li><li><a href=\"#H23\" id=\"outline-link-H23\">DIAGNOSIS</a></li><li><a href=\"#H28371285\" id=\"outline-link-H28371285\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H1630212384\" id=\"outline-link-H1630212384\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H24\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H25\" id=\"outline-link-H25\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/5664|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=RHEUM/58184\" class=\"graphic graphic_diagnosticimage\">- Mutilans in psoriasis x ray</a></li></ul></li><li><div id=\"DERM/5664|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/87343\" class=\"graphic graphic_picture\">- Scalp psoriasis</a></li><li><a href=\"image.htm?imageKey=DERM/54581\" class=\"graphic graphic_picture\">- Psoriasis plaque</a></li><li><a href=\"image.htm?imageKey=DERM/87443\" class=\"graphic graphic_picture\">- Plaque psoriasis 3</a></li><li><a href=\"image.htm?imageKey=DERM/87441\" class=\"graphic graphic_picture\">- Plaque psoriasis 2</a></li><li><a href=\"image.htm?imageKey=DERM/99437\" class=\"graphic graphic_picture\">- Plaque psoriasis on back</a></li><li><a href=\"image.htm?imageKey=DERM/99438\" class=\"graphic graphic_picture\">- Inverse psoriasis axilla</a></li><li><a href=\"image.htm?imageKey=DERM/94790\" class=\"graphic graphic_picture\">- Pustular psoriasis erythema and scale</a></li><li><a href=\"image.htm?imageKey=DERM/99440\" class=\"graphic graphic_picture\">- Erythrodermic psoriasis extremity</a></li><li><a href=\"image.htm?imageKey=DERM/69799\" class=\"graphic graphic_picture\">- Acrodermatitis continua of Hallopeau</a></li><li><a href=\"image.htm?imageKey=DERM/99445\" class=\"graphic graphic_picture\">- Psoriasis at umbilicus</a></li><li><a href=\"image.htm?imageKey=DERM/99446\" class=\"graphic graphic_picture\">- Psoriasis in ear</a></li><li><a href=\"image.htm?imageKey=DERM/93909\" class=\"graphic graphic_picture\">- Palmoplantar plaque psoriasis</a></li><li><a href=\"image.htm?imageKey=DERM/99481\" class=\"graphic graphic_picture\">- Palmoplantar psoriasis</a></li><li><a href=\"image.htm?imageKey=DERM/55141\" class=\"graphic graphic_picture\">- Guttate psoriasis 1</a></li><li><a href=\"image.htm?imageKey=DERM/64836\" class=\"graphic graphic_picture\">- Guttate psoriasis 2</a></li><li><a href=\"image.htm?imageKey=DERM/95194\" class=\"graphic graphic_picture\">- Generalized pustular psoriasis</a></li><li><a href=\"image.htm?imageKey=DERM/62582\" class=\"graphic graphic_picture\">- Palmoplantar pustulosis - heel</a></li><li><a href=\"image.htm?imageKey=DERM/75404\" class=\"graphic graphic_picture\">- Palmoplantar pustulosis - plantar</a></li><li><a href=\"image.htm?imageKey=PC/71225\" class=\"graphic graphic_picture\">- Erythrodermic psoriasis</a></li><li><a href=\"image.htm?imageKey=DERM/99439\" class=\"graphic graphic_picture\">- Inverse psoriasis axilla 2</a></li><li><a href=\"image.htm?imageKey=DERM/78531\" class=\"graphic graphic_picture\">- Inverse psoriasis chest</a></li><li><a href=\"image.htm?imageKey=DERM/76200\" class=\"graphic graphic_picture\">- Inverse psoriasis groin</a></li><li><a href=\"image.htm?imageKey=DERM/50615\" class=\"graphic graphic_picture\">- Inverse psoriasis gluteal 1</a></li><li><a href=\"image.htm?imageKey=DERM/62411\" class=\"graphic graphic_picture\">- Inverse psoriasis gluteal 2</a></li><li><a href=\"image.htm?imageKey=DERM/70962\" class=\"graphic graphic_picture\">- Nail psoriasis pits</a></li><li><a href=\"image.htm?imageKey=DERM/66374\" class=\"graphic graphic_picture\">- Nail psoriasis oil drop</a></li><li><a href=\"image.htm?imageKey=DERM/53509\" class=\"graphic graphic_picture\">- Nail psoriasis hyperkeratosis</a></li><li><a href=\"image.htm?imageKey=DERM/99441\" class=\"graphic graphic_picture\">- Diaper psoriasis</a></li><li><a href=\"image.htm?imageKey=DERM/99442\" class=\"graphic graphic_picture\">- Diaper psoriasis with maceration</a></li><li><a href=\"image.htm?imageKey=DERM/99443\" class=\"graphic graphic_picture\">- Scalp psoriasis in child</a></li><li><a href=\"image.htm?imageKey=RHEUM/70503\" class=\"graphic graphic_picture\">- DIP joints psoriatic arthritis</a></li><li><a href=\"image.htm?imageKey=RHEUM/51683\" class=\"graphic graphic_picture\">- Arthritis mutilans in psoriasis</a></li><li><a href=\"image.htm?imageKey=DERM/56410\" class=\"graphic graphic_picture\">- Seborrheic dermatitis face</a></li><li><a href=\"image.htm?imageKey=DERM/53407\" class=\"graphic graphic_picture\">- Seborrheic dermatitis axilla</a></li><li><a href=\"image.htm?imageKey=DERM/76985\" class=\"graphic graphic_picture\">- Seborrheic dermatitis scalp 2</a></li><li><a href=\"image.htm?imageKey=DERM/65167\" class=\"graphic graphic_picture\">- Seborrheic dermatitis face 3</a></li><li><a href=\"image.htm?imageKey=DERM/73843\" class=\"graphic graphic_picture\">- Lichen simplex chronicus ankle</a></li><li><a href=\"image.htm?imageKey=DERM/64525\" class=\"graphic graphic_picture\">- Adult atopic dermatitis 1</a></li><li><a href=\"image.htm?imageKey=DERM/55375\" class=\"graphic graphic_picture\">- Adult chronic atopic dermatitis</a></li><li><a href=\"image.htm?imageKey=ALLRG/56461\" class=\"graphic graphic_picture\">- Atopic dermatitis infantile II</a></li><li><a href=\"image.htm?imageKey=DERM/96164\" class=\"graphic graphic_picture\">- Nummular eczema 2</a></li><li><a href=\"image.htm?imageKey=DERM/58067\" class=\"graphic graphic_picture\">- Nummular eczema legs</a></li><li><a href=\"image.htm?imageKey=DERM/99892\" class=\"graphic graphic_picture\">- Tinea corporis on extremity</a></li><li><a href=\"image.htm?imageKey=DERM/99894\" class=\"graphic graphic_picture\">- Candidal intertrigo</a></li><li><a href=\"image.htm?imageKey=DERM/85579\" class=\"graphic graphic_picture\">- Subungual onychomycosis</a></li></ul></li><li><div id=\"DERM/5664|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/99889\" class=\"graphic graphic_table\">- Drugs associated with psoriasiform drug eruptions</a></li><li><a href=\"image.htm?imageKey=PC/60541\" class=\"graphic graphic_table\">- Fitzpatrick skin phototypes</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-psoriatic-arthritis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of psoriatic arthritis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=comorbid-disease-in-psoriasis\" class=\"medical medical_review\">Comorbid disease in psoriasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cradle-cap-and-seborrheic-dermatitis-in-infants\" class=\"medical medical_review\">Cradle cap and seborrheic dermatitis in infants</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dermatophyte-tinea-infections\" class=\"medical medical_review\">Dermatophyte (tinea) infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dermatoses-of-pregnancy\" class=\"medical medical_review\">Dermatoses of pregnancy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=erythroderma-in-adults\" class=\"medical medical_review\">Erythroderma in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=guttate-psoriasis\" class=\"medical medical_review\">Guttate psoriasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nail-psoriasis\" class=\"medical medical_review\">Nail psoriasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nummular-eczema\" class=\"medical medical_review\">Nummular eczema</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=onychomycosis-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">Onychomycosis: Epidemiology, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=palmoplantar-pustulosis-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">Palmoplantar pustulosis: Epidemiology, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-of-psoriatic-arthritis\" class=\"medical medical_review\">Pathogenesis of psoriatic arthritis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-of-spondyloarthritis\" class=\"medical medical_review\">Pathogenesis of spondyloarthritis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathophysiology-of-psoriasis\" class=\"medical medical_review\">Pathophysiology of psoriasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=psoriasis-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Psoriasis (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=psoriasis-the-basics\" class=\"medical medical_basics\">Patient education: Psoriasis (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=psoriatic-arthritis-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Psoriatic arthritis (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=psoriasis-in-children-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Psoriasis in children: Epidemiology, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pustular-psoriasis-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Pustular psoriasis: Pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=seborrheic-dermatitis-in-adolescents-and-adults\" class=\"medical medical_review\">Seborrheic dermatitis in adolescents and adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=skin-biopsy-techniques\" class=\"medical medical_review\">Skin biopsy techniques</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-psoriasis\" class=\"medical medical_society_guidelines\">Society guideline links: Psoriasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-psoriasis-in-adults\" class=\"medical medical_review\">Treatment of psoriasis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-psoriatic-arthritis\" class=\"medical medical_review\">Treatment of psoriatic arthritis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vitamin-d-and-extraskeletal-health\" class=\"medical medical_review\">Vitamin D and extraskeletal health</a></li></ul></div></div>","javascript":null}